Versant Capital Management’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-828
| Closed | -$7K | – | 1625 |
|
|
2020
Q3 | $7K | Buy |
828
+406
| +96% | +$3.86K | ﹤0.01% | 786 |
|
|
2020
Q2 | $3K | Buy |
422
+47
| +13% | +$360 | ﹤0.01% | 1023 |
|
|
2020
Q1 | $2K | Sell |
375
-268
| -42% | -$2.36K | ﹤0.01% | 1080 |
|
|
2019
Q4 | $7K | Sell |
643
-71
| -10% | -$776 | ﹤0.01% | 856 |
|
|
2019
Q3 | $8K | Buy |
714
+221
| +45% | +$2.33K | ﹤0.01% | 820 |
|
|
2019
Q2 | $4K | Buy |
493
+237
| +93% | +$2.56K | ﹤0.01% | 1064 |
|
|
2019
Q1 | $3K | Buy |
256
+151
| +144% | +$2.25K | ﹤0.01% | 1300 |
|
|
2018
Q4 | $1K | Sell |
105
-13
| -11% | -$248 | ﹤0.01% | 1429 |
|
|
2018
Q3 | $2K | Buy |
118
+45
| +62% | +$1.02K | ﹤0.01% | 1359 |
|
|
2018
Q2 | $1K | Hold |
73
| – | – | ﹤0.01% | 1465 |
|
|
2018
Q1 | $1K | Buy |
+73
| New | +$1.24K | ﹤0.01% | 1448 |
|
|
2017
Q4 | – | Sell |
-20
| Closed | – | – | 1702 |
|
|
2017
Q3 | $0 | Buy |
20
+7
| +54% | +$130 | ﹤0.01% | 1624 |
|
|
2017
Q2 | $0 | Sell |
13
-14
| -52% | -$277 | ﹤0.01% | 1593 |
|
|
2017
Q1 | $0 | Sell |
27
-127
| -82% | -$3.04K | ﹤0.01% | 1586 |
|
|
2016
Q4 | $5K | Buy |
154
+24
| +18% | +$717 | ﹤0.01% | 1039 |
|
|
2016
Q3 | $3K | Buy |
130
+113
| +665% | +$2.82K | ﹤0.01% | 1139 |
|
|
2016
Q2 | $0 | Buy |
+17
| New | +$390 | ﹤0.01% | 1495 |
|
Versant Capital Management's AMAG Position: Q4 2020 in Review
Versant Capital Management sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 828 shares — an estimated $7K sold.
Versant Capital Management first reported a position in AMAG in Q2 2016 and held it in 17 quarters. The position peaked at $8K in Q3 2019. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.
- Versant Capital Management reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- Versant Capital Management sold 828 AMAG Pharmaceuticals shares in Q4 2020, an estimated $7K.
- Versant Capital Management first reported a position in AMAG Pharmaceuticals in Q2 2016 and held it in 17 quarters.
- Versant Capital Management's AMAG Pharmaceuticals position peaked at $8K in Q3 2019.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.
Based on Versant Capital Management's 13F filing for Q4 2020, filed 8 Feb 2021.